&Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
&Partners's AMGN Position: Q2 2026 in Review
&Partners increased its Amgen (AMGN) stake by 0.29% in Q2 2026, buying an estimated $276K and bringing the position to 280,838 shares worth $102M. The position accounts for 0.42% of the portfolio, ranked #44.
&Partners first reported a position in AMGN in Q2 2020 and has held it in 24 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- &Partners held 280,838 shares of Amgen worth $102M as of Q2 2026.
- &Partners bought 806 Amgen shares in Q2 2026, an estimated $276K.
- Amgen made up 0.42% of &Partners's portfolio in Q2 2026, its #44 holding.
- &Partners first reported a position in Amgen in Q2 2020 and has held it in 24 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.